PTJ
CLB icon

Paul Tudor Jones’s Core Laboratories CLB Stock Holding History

Paul Tudor Jones’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,701
Closed -$654K – 1639
2021
Q1 		$654K Sell
22,701
-53,138
-70% -$1.82M 0.01% 1037
2020
Q4 		$2.01M Sell
75,839
-20,921
-22% -$427K 0.06% 418
2020
Q3 		$1.48M Buy
+96,760
New +$2.03M 0.06% 412
2020
Q1 		– Sell
-15,523
Closed -$585K – 1086
2019
Q4 		$585K Buy
+15,523
New +$697K 0.03% 671
2018
Q2 		– Sell
-3,454
Closed -$374K – 1063
2018
Q1 		$374K Buy
+3,454
New +$382K 0.01% 662
2017
Q3 		– Sell
-14,343
Closed -$1.45M – 1105
2017
Q2 		$1.45M Buy
+14,343
New +$1.55M 0.04% 247
2014
Q3 		– Sell
-1,711
Closed -$286K – 1356
2014
Q2 		$286K Buy
+1,711
New +$304K 0.01% 863

Other funds holding CLB

FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's CLB Position: Q2 2021 in Review

Paul Tudor Jones sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 22,701 shares — an estimated $654K sold.

Paul Tudor Jones first reported a position in CLB in Q2 2014 and held it in 7 quarters. The position peaked at $2.01M in Q4 2020. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Paul Tudor Jones reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 22,701 Core Laboratories shares in Q2 2021, an estimated $654K.
  • Paul Tudor Jones first reported a position in Core Laboratories in Q2 2014 and held it in 7 quarters.
  • Paul Tudor Jones's Core Laboratories position peaked at $2.01M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.